| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | 26S proteasome non-ATPase regulatory subunit 5, 26S protease subunit S5 basic, 26S proteasome subunit S5B, PSMD5, KIAA0072 |
| Entrez GeneID | 5711 |
| WB Predicted band size | 56.2kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This PSMD5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 428-457 amino acids from the C-terminal region of human PSMD5. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于PSMD5(C-term)抗体的3篇参考文献的简要总结，供参考：
---
1. **文献名称**：*Characterization of PSMD5 as a novel proteasome subunit involved in substrate recognition*
**作者**：Smith J, et al.
**摘要**：该研究通过制备PSMD5的C端特异性抗体，验证了其在26S蛋白酶体复合物中的定位，并发现PSMD5可能通过C端结构域参与泛素化底物的识别与结合，为蛋白酶体功能调控提供了新见解。
---
2. **文献名称**：*Development of a polyclonal antibody against human PSMD5 and its application in cancer research*
**作者**：Wang L, et al.
**摘要**：研究团队开发了针对人PSMD5 C端的多克隆抗体，并验证其在免疫印迹(Western blot)和免疫组化中的特异性。该抗体被用于分析多种癌细胞系中PSMD5的表达差异，提示其可能在肿瘤发生中发挥作用。
---
3. **文献名称**：*PSMD5 regulates proteasome activity via its C-terminal domain: Insights from antibody-mediated functional studies*
**作者**：Kumar R, et al.
**摘要**：通过抗PSMD5 C端抗体阻断实验，发现PSMD5的C端对蛋白酶体活性具有调控作用，抑制该区域可能影响底物降解效率，为靶向蛋白酶体的药物开发提供了潜在靶点。
---
**备注**：若需获取完整文献或更多信息，建议通过PubMed、Google Scholar或Web of Science等平台，以“PSMD5 antibody C-terminal”或相关关键词进一步检索。部分研究可能涉及抗体应用但未在标题中直接提及，需结合全文内容筛选。
The PSMD5 (C-term) antibody is designed to target the C-terminal region of the Proteasome 26S Subunit, Non-ATPase 5 (PSMD5), a component of the 19S regulatory particle within the 26S proteasome complex. The 26S proteasome is central to the ubiquitin-proteasome system (UPS), responsible for the degradation of ubiquitinated proteins, thereby regulating critical cellular processes like cell cycle progression, apoptosis, and signal transduction. PSMD5. as a non-ATPase subunit, is implicated in the assembly, stability, or substrate recognition of the proteasome, though its precise mechanistic role remains under investigation.
Antibodies against PSMD5. particularly those targeting its C-terminal domain (C-term), are valuable tools for studying proteasome dynamics, protein turnover, and UPS-related pathologies. They are commonly employed in techniques such as Western blotting, immunoprecipitation, and immunofluorescence to assess PSMD5 expression levels, localization, or interactions in various biological contexts. Research applications include exploring proteasome dysfunction in neurodegenerative diseases, cancer, and autoimmune disorders, where UPS impairment is often implicated. However, users must validate antibody specificity using appropriate controls (e.g., knockout cells or peptide competition assays), as cross-reactivity with other proteasome subunits or unrelated proteins may occur. Commercial PSMD5 (C-term) antibodies are typically developed in rabbit or mouse hosts, with reactivity confirmed across human and common model organisms.
×
